Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Monika Joshi

Showing results (81-90 of 122) with videos related to

Pageof 13
Sort By:
BMJ Supportive & Palliative Care|January 10, 2021
Group-led creative writing and behavioural health in cancer: a randomised clinical trialDarya Nesterova, Junjia Zhu, Courtney Kramer, et al.
Cancer Reports (Hoboken, N.J.)|June 18, 2025
Facilitating Advance Care Planning Conversations Among Patients With Cancer and Their Care Partners Utilizing a Conversation Game: A Pilot StudyKylee Kimbel, Michael Hayes, Morgan Bucher, et al.
Human Pathology|October 26, 2018
Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading systemMichael Zaleski, Augustyna Gogoj, Vonn Walter, et al.
Seminars in Radiation Oncology|December 14, 2022
Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder CancerBhanuPrasad Venkatesulu, Stanley L Liauw, Monika Joshi, et al.
Clinical Genitourinary Cancer|November 7, 2022
Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources UniformlyAndrea Necchi, Monika Joshi, Rick Bangs, et al.
European Urology Focus|March 20, 2021
Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b StudyMonika Joshi, Sheldon L Holder, Junjia Zhu, et al.
Nature Communications|February 1, 2024
Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043Yousef Zakharia, Eric A Singer, Satwik Acharyya, et al.
The Oncologist|April 8, 2016
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-AnalysisMing Yin, Monika Joshi, Richard P Meijer, et al.
Structure (London, England : 1993)|July 19, 2024
Structural insights into an atypical histone binding mechanism by a PHD fingerSabrina Grégoire, Janelle Grégoire, Yidai Yang, et al.
Nucleic Acids Research|April 7, 2017
Molecular basis for the methylation specificity of ATXR5 for histone H3Elisa Bergamin, Sabina Sarvan, Josée Malette, et al.
Pageof 13

Showing results (81-90 of 122) with videos related to

Sort By:
Pageof 13
BMJ Supportive & Palliative Care|January 10, 2021
Group-led creative writing and behavioural health in cancer: a randomised clinical trialDarya Nesterova, Junjia Zhu, Courtney Kramer, et al.
Cancer Reports (Hoboken, N.J.)|June 18, 2025
Facilitating Advance Care Planning Conversations Among Patients With Cancer and Their Care Partners Utilizing a Conversation Game: A Pilot StudyKylee Kimbel, Michael Hayes, Morgan Bucher, et al.
Human Pathology|October 26, 2018
Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading systemMichael Zaleski, Augustyna Gogoj, Vonn Walter, et al.
Seminars in Radiation Oncology|December 14, 2022
Multidisciplinary Management and Radiotherapy Recommendations for Clinically and Pathologically Node-positive Bladder CancerBhanuPrasad Venkatesulu, Stanley L Liauw, Monika Joshi, et al.
Clinical Genitourinary Cancer|November 7, 2022
Disparities in Access to Novel Systemic Therapies in Patients With Urinary Tract Cancer: Propagating Access, Policies and Resources UniformlyAndrea Necchi, Monika Joshi, Rick Bangs, et al.
European Urology Focus|March 20, 2021
Avelumab in Combination with Eribulin Mesylate in Metastatic Urothelial Carcinoma: BTCRC GU-051, a Phase 1b StudyMonika Joshi, Sheldon L Holder, Junjia Zhu, et al.
Nature Communications|February 1, 2024
Durvalumab and guadecitabine in advanced clear cell renal cell carcinoma: results from the phase Ib/II study BTCRC-GU16-043Yousef Zakharia, Eric A Singer, Satwik Acharyya, et al.
The Oncologist|April 8, 2016
Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer: A Systematic Review and Two-Step Meta-AnalysisMing Yin, Monika Joshi, Richard P Meijer, et al.
Structure (London, England : 1993)|July 19, 2024
Structural insights into an atypical histone binding mechanism by a PHD fingerSabrina Grégoire, Janelle Grégoire, Yidai Yang, et al.
Nucleic Acids Research|April 7, 2017
Molecular basis for the methylation specificity of ATXR5 for histone H3Elisa Bergamin, Sabina Sarvan, Josée Malette, et al.
Pageof 13